Literature DB >> 31240564

Clinical and anorectal manometry profile of patients with functional constipation and constipation-predominant irritable bowel syndrome.

Omesh Goyal1, Monika Bansal2, Ajit Sood2.   

Abstract

BACKGROUND: Functional constipation (FC) and constipation-predominant irritable bowel syndrome (IBS-C) have significant healthcare impact. Clinical and investigative data of patients with these disorders in Indian population is scarce. We aimed to compare the clinical and anorectal manometric profile of patients with FC and IBS-C.
METHODS: Consecutive patients with chronic constipation undergoing anorectal manometry (ARM) and balloon expulsion test (BET) were enrolled. Thirty healthy volunteers served as controls (HC). Functional defecatory disorder (FDD) was diagnosed according to ROME IV criteria if both ARM and BET were abnormal.
RESULTS: Of the 231 patients enrolled (median age 47 years, 87.8% males), FC and IBS-C were diagnosed in 132 (57.1%) and 99 (42.9%) patients, respectively. Significant clinical differences between FC and IBS-C patients included older age, lower stool frequency/week, higher frequency of straining, and greater frequency  of incomplete evacuation (p < 0.001). ARM revealed abnormal defecatory pattern in 55.3% (n = 73) FC patients and 47.5% (n = 47) IBS-C patients. Of them, 54.7% (40/73) of FC patients had inadequate defecatory propulsion while 89.4% (42/47) of the IBS-C patients had dyssynergic defecation (p < 0.001). Abnormal BET was seen in 67.4% of FC patients and 43.4% of IBS-C patients. Thus, FDD was diagnosed in 55.3% and 46.5% of FC and IBS-C patients, respectively. Rectal hyposensitivity was present in 60.6% of FC patients compared with 2% of IBS-C patients (p < 0.001).
CONCLUSIONS: There were significant differences in clinical and manometric profile of FC and IBS-C patients. Compared with IBS-C patients, FC patients were older, had higher prevalence of FDD, less often had dyssynergic defecation, and had higher prevalence of rectal hyposensitivity.

Entities:  

Keywords:  Anorectal manometry; Balloon expulsion test; Chronic constipation; Functional constipation; Irritable bowel syndrome

Mesh:

Year:  2019        PMID: 31240564     DOI: 10.1007/s12664-019-00953-8

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  35 in total

1.  Stool form scale as a useful guide to intestinal transit time.

Authors:  S J Lewis; K W Heaton
Journal:  Scand J Gastroenterol       Date:  1997-09       Impact factor: 2.423

Review 2.  Asian consensus on irritable bowel syndrome.

Authors:  Kok-Ann Gwee; Young-Tae Bak; Uday Chand Ghoshal; Sutep Gonlachanvit; Oh Young Lee; Kwong Ming Fock; Andrew Seng Boon Chua; Ching-Liang Lu; Khean-Lee Goh; Chomsri Kositchaiwat; Govind Makharia; Hyo-Jin Park; Full-Young Chang; Shin Fukudo; Myung-Gyu Choi; Shobna Bhatia; Meiyun Ke; Xiaohua Hou; Michio Hongo
Journal:  J Gastroenterol Hepatol       Date:  2010-07       Impact factor: 4.029

3.  Clinical and investigative assessment of constipation: a study from a referral center in western India.

Authors:  Nimish Shah; Rajiv Baijal; Praveen Kumar; Deepak Gupta; Sandeep Kulkarni; Soham Doshi; Deepak Amarapurkar
Journal:  Indian J Gastroenterol       Date:  2014-10-15

Review 4.  A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation.

Authors:  Dave Nellesen; Kimberly Yee; Anita Chawla; Barbara Edelman Lewis; Robyn T Carson
Journal:  J Manag Care Pharm       Date:  2013 Nov-Dec

Review 5.  Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception.

Authors:  W E Whitehead; O S Palsson
Journal:  Gastroenterology       Date:  1998-11       Impact factor: 22.682

6.  Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin.

Authors:  Chander Shekhar; Phillip J Monaghan; Julie Morris; Basma Issa; Peter J Whorwell; Brian Keevil; Lesley A Houghton
Journal:  Gastroenterology       Date:  2013-07-19       Impact factor: 22.682

7.  Altered rectal perception in irritable bowel syndrome is associated with symptom severity.

Authors:  Iris Posserud; Alma Syrous; Lina Lindström; Jan Tack; Hasse Abrahamsson; Magnus Simrén
Journal:  Gastroenterology       Date:  2007-07-25       Impact factor: 22.682

8.  Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian Society of Gastroenterology Task Force.

Authors:  Uday C Ghoshal; Philip Abraham; Chetan Bhatt; Gourdas Choudhuri; Shobna J Bhatia; K T Shenoy; N H Banka; Kalyan Bose; N P Bohidar; Karmabir Chakravartty; N Chandra Shekhar; Nutan Desai; Usha Dutta; Goutam Das; Sangeet Dutta; V K Dixit; B D Goswami; R K Jain; Sunil Jain; V Jayanthi; Rakesh Kochhar; Ajay Kumar; Govind Makharia; Shrikant V Mukewar; V G Mohan Prasad; Alok Mohanty; A T Mohan; B S Sathyaprakash; B Prabhakar; Mathew Philip; E Peda Veerraju; Gautam Ray; Ramesh Roop Rai; A K Seth; Atul Sachdeva; Shivaram Prasad Singh; Ajit Sood; Varghese Thomas; Shridhar Tiwari; Manu Tandan; R Upadhyay; J C Vij
Journal:  Indian J Gastroenterol       Date:  2008 Jan-Feb

9.  Frequency, spectrum, and factors associated with fecal evacuation disorders among patients with chronic constipation referred to a tertiary care center in northern India.

Authors:  Uday C Ghoshal; Abhai Verma; Asha Misra
Journal:  Indian J Gastroenterol       Date:  2016-04-04

10.  Prevalence of irritable bowel syndrome: a community based study from northern India.

Authors:  Govind K Makharia; Anil K Verma; Ritvik Amarchand; Anil Goswami; Prashant Singh; Abhishek Agnihotri; Faizul Suhail; Anand Krishnan
Journal:  J Neurogastroenterol Motil       Date:  2011-01-26       Impact factor: 4.924

View more
  1 in total

1.  Behavioral Intervention in Children with Functional Abdominal Pain Disorders: A Promising Option.

Authors:  Shubhanshu Saini; Manish Narang; Shruti Srivastava; Dheeraj Shah
Journal:  Turk J Gastroenterol       Date:  2021-05       Impact factor: 1.852

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.